Shanghai Kaibao Pharmaceutical (300039) — Cash Flow-to-Debt Ratio
Shanghai Kaibao Pharmaceutical (300039) has a Cash Flow-to-Debt Ratio of 0.46x as of September 2025, meaning its operating cash flow of CN¥190.98 Million could theoretically repay 0% of its total liabilities (CN¥412.55 Million) in one year. Explore 300039 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Kaibao Pharmaceutical Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Shanghai Kaibao Pharmaceutical across 19 annual periods. Also explore Shanghai Kaibao Pharmaceutical asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shanghai Kaibao Pharmaceutical (2006–2024)
Year-by-year debt coverage analysis for Shanghai Kaibao Pharmaceutical. For market capitalisation and broader financial context, see 300039 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.67x | CN¥278.95 Million | CN¥415.45 Million | ▼ -4.1% |
| 2023 | 0.70x | CN¥382.66 Million | CN¥546.82 Million | ▼ -7.4% |
| 2022 | 0.76x | CN¥376.42 Million | CN¥498.24 Million | ▲ +86.3% |
| 2021 | 0.41x | CN¥126.08 Million | CN¥310.90 Million | ▼ -51.6% |
| 2020 | 0.84x | CN¥250.65 Million | CN¥298.96 Million | ▼ -31.5% |
| 2019 | 1.22x | CN¥334.09 Million | CN¥273.01 Million | ▲ +22.3% |
| 2018 | 1.00x | CN¥262.36 Million | CN¥262.26 Million | ▲ +27.9% |
| 2017 | 0.78x | CN¥245.76 Million | CN¥314.26 Million | ▼ -18.6% |
| 2016 | 0.96x | CN¥314.88 Million | CN¥327.61 Million | ▲ +23.8% |
| 2015 | 0.78x | CN¥327.08 Million | CN¥421.16 Million | ▼ -36.0% |
| 2014 | 1.21x | CN¥282.38 Million | CN¥232.72 Million | ▼ -26.0% |
| 2013 | 1.64x | CN¥270.23 Million | CN¥164.72 Million | ▼ -4.1% |
| 2012 | 1.71x | CN¥243.32 Million | CN¥142.29 Million | ▲ +105.2% |
| 2011 | 0.83x | CN¥98.31 Million | CN¥117.97 Million | ▲ +461.7% |
| 2010 | 0.15x | CN¥19.79 Million | CN¥133.39 Million | ▼ -44.0% |
| 2009 | 0.26x | CN¥52.74 Million | CN¥199.20 Million | ▲ +45.8% |
| 2008 | 0.18x | CN¥18.70 Million | CN¥102.95 Million | ▼ -33.9% |
| 2007 | 0.27x | CN¥23.27 Million | CN¥84.64 Million | ▲ +0.2% |
| 2006 | 0.27x | CN¥19.70 Million | CN¥71.80 Million | — |